Intrinsic Value of S&P & Nasdaq Contact Us

Cameco Corporation CCJ NYSE

NYSE • Energy • Uranium • CA • USD

SharesGrow Score
72/100
5/7 Pass
SharesGrow Intrinsic Value
$110.28
-5%
Analyst Price Target
$125.91
+8.5%

Cameco Corporation (CCJ) is a Uranium company in the Energy sector, currently trading at $116.06. It has a SharesGrow Score of 72/100, indicating a above average investment profile with 5 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of CCJ = $110.28 (-5% from the current price, the stock appears fairly valued). Analyst consensus target is CCJ = $126 (+8.5% upside).

Valuation: CCJ trades at a trailing Price-to-Earnings (P/E) of 118.7 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 2.19.

Financials: revenue is $3.5B, +23.6%/yr average growth. Net income is $589M, growing at +164.7%/yr. Net profit margin is 16.9% (healthy). Gross margin is 26.7% (+14.2 pp trend).

Balance sheet: total debt is $1.0B against $6.9B equity (Debt-to-Equity (D/E) ratio 0.15, conservative). Current ratio is 2.47 (strong liquidity). Debt-to-assets is 9.9%. Total assets: $10.3B.

Analyst outlook: 13 / 19 analysts rate CCJ as buy (68%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value 32/100 (Fail), Growth 100/100 (Pass), Past 100/100 (Pass), Health 83/100 (Pass), Moat 59/100 (Partial), Future 61/100 (Pass), Income 70/100 (Pass).

$125.91
▲ 8.49% Upside
Average Price Target
Based on 19 Wall Street analysts offering 12-month price targets for Cameco Corporation, the average price target is $125.91, with a high forecast of $147.00, and a low forecast of $99.74.
Highest Price Target
$147.00
Average Price Target
$125.91
Lowest Price Target
$99.74

CCJ SharesGrow Score Overview

72/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 32/100
Valuation — P/E, PEG, Forward PEG
GROWTH 100/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 83/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 59/100
Gross margin is + market cap
FUTURE 61/100
Analyst outlook — as buy
INCOME 70/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — CCJ

VALUE Fail
32/100
CCJ trades at a trailing Price-to-Earnings (P/E) of 118.7 (S&P 500 average ~25). Forward PEG 2.19 — overvalued. Trailing PEG 9.57. Analyst consensus target is $126, implying +8.6% from the current price $116. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
100/100
CCJ: +23.6%/yr revenue is, +164.7%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Pass
100/100
CCJ: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
HEALTH Pass
83/100
Balance sheet CCJ: Debt-to-Equity (D/E) ratio 0.15 (conservative), Current ratio is 2.47 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
59/100
CCJ: Gross margin is 26.7% (+14.2 pp trend), $51B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 59/100. ≥ 70 = Pass.
View details →
FUTURE Pass
61/100
Analyst outlook: 13 / 19 analysts rate CCJ as buy (68%). Analyst consensus target is $126 (+8.6% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Pass
70/100
CCJ: Net profit margin is 16.9%. healthy (≥15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range35-135.24
Volume3.37M
Avg Volume (30D)3.99M
Market Cap$50.54B
Beta (1Y)1.01
Dividend Yield$0.1714
Share Statistics
EPS (TTM)1.35
Shares Outstanding$435.36M
IPO Date1996-03-14
Employees730
CEOTimothy S. Gitzel
Financial Highlights & Ratios
Revenue (TTM)$3.48B
Gross Profit$929.85M
EBITDA$885.3M
Net Income$589.1M
Operating Income$580.42M
Total Cash$1.21B
Total Debt$1.02B
Net Debt$-91.91M
Total Assets$10.29B
Price / Earnings (P/E)86
Price / Sales (P/S)14.53
Analyst Forecast
1Y Price Target$131.00
Target High$147.00
Target Low$99.74
Upside+12.9%
Rating ConsensusBuy
Analysts Covering19
Buy 68% Hold 21% Sell 11%
Price Target Summary
Company Info
CountryCA
ExchangeNYSE
CurrencyUSD
ISINCA13321L1085

Price Chart

CCJ
Cameco Corporation  ·  NYSE
Energy • Uranium
35.00 52WK RANGE 135.24
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message